Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Alzheimer's Disease

  Free Subscription


1 Alzheimers Dement
1 Am J Epidemiol
3 Am J Geriatr Psychiatry
2 Brain
3 Curr Alzheimer Res
10 J Alzheimers Dis
1 J Neurol Neurosurg Psychiatry
1 Neurobiol Aging
4 Neurobiol Dis
3 Neurology
3 Neurosci Lett

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Alzheimers Dement

  1. BABILONI C, Arakaki X, Azami H, Bennys K, et al
    Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: Recommendations of an expert panel.
    Alzheimers Dement. 2021 Apr 15. doi: 10.1002/alz.12311.
    PubMed         Abstract available

    Am J Epidemiol

  2. BRENOWITZ WD, Zimmerman SC, Filshtein TJ, Yaffe K, et al
    Extension of Mendelian Randomization to Identify Earliest Manifestations of Alzheimer's Disease: Genetic Risk Score for Alzheimer's Disease Reduces BMI by Age 50.
    Am J Epidemiol. 2021 Apr 12. pii: 6222073. doi: 10.1093.
    PubMed         Abstract available

    Am J Geriatr Psychiatry

    Commentary on "Cannabinoids for Agitation in Alzheimer's Disease".
    Am J Geriatr Psychiatry. 2021 Mar 19. pii: S1064-7481(21)00262.

  4. KEMP EC, Ebner MK, Ramanan S, Godek TA, et al
    Statin Use and Risk of Cognitive Decline in the ADNI Cohort.
    Am J Geriatr Psychiatry. 2020;28:507-517.
    PubMed         Abstract available

  5. ORSO B, Mattei C, Arnaldi D, Massa F, et al
    Clinical and MRI Predictors of Conversion From Mild Behavioural Impairment to Dementia.
    Am J Geriatr Psychiatry. 2020;28:755-763.
    PubMed         Abstract available


  6. TOME SO, Thal DR
    Co-pathologies in Alzheimer's disease: just multiple pathologies or partners in crime?
    Brain. 2021;144:706-708.

  7. OZAWA S, Hori Y, Shimizu Y, Taniguchi A, et al
    Photo-oxygenation by a biocompatible catalyst reduces amyloid-beta levels in Alzheimer's disease mice.
    Brain. 2021 Apr 14. pii: 6224831. doi: 10.1093.
    PubMed         Abstract available

    Curr Alzheimer Res

  8. GUO L, Ravindran N, Hill D, Cordeiro MF, et al
    Retinal Changes in Transgenic Mouse Models of Alzheimer's Disease.
    Curr Alzheimer Res. 2021 Apr 13. pii: CAR-EPUB-115332.
    PubMed         Abstract available

  9. BENTHAM C, De Marco M, Venneri A
    Cerebrovascular Pathology and Responsiveness to Treatment in Alzheimer's Disease: A Systematic Review.
    Curr Alzheimer Res. 2021 Apr 14. pii: CAR-EPUB-115333.
    PubMed         Abstract available

  10. AGHAKHANYAN G, Saur D, Rullmann M, Weise CM, et al
    PET/MRI Delivers Multimodal Brain Signature in Alzheimer's Disease with De Novo PSEN1 Mutation.
    Curr Alzheimer Res. 2021 Apr 13. pii: CAR-EPUB-115330.
    PubMed         Abstract available

    J Alzheimers Dis

  11. LI J, Bur AM, Villwock MR, Shankar S, et al
    Olfactory Phenotypes Differentiate Cognitively Unimpaired Seniors from Alzheimer's Disease and Mild Cognitive Impairment: A Combined Machine Learning and Traditional Statistical Approach.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD210175. doi: 10.3233/JAD-210175.
    PubMed         Abstract available

    Repurposing Licensed Drugs for Use Against Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD210080. doi: 10.3233/JAD-210080.
    PubMed         Abstract available

  13. SAKURAI K, Kaneda D, Inui S, Uchida Y, et al
    Simple Quantitative Indices for the Differentiation of Advanced-Stage Alzheimer's Disease and Other Limbic Tauopathies.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD210043. doi: 10.3233/JAD-210043.
    PubMed         Abstract available

  14. EEZA MNH, Singer R, Hofling C, Matysik J, et al
    Metabolic Profiling of Suprachiasmatic Nucleus Reveals Multifaceted Effects in an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2021 Apr 3. pii: JAD201575. doi: 10.3233/JAD-201575.
    PubMed         Abstract available

  15. MULLER L, Kirschstein T, Kohling R, Kuhla A, et al
    Neuronal Hyperexcitability in APPSWE/PS1dE9 Mouse Models of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD201540. doi: 10.3233/JAD-201540.
    PubMed         Abstract available

  16. HALMINEN O, Vesikansa A, Mehtala J, Horhammer I, et al
    Early Start of Anti-Dementia Medication Delays Transition to 24-Hour Care in Alzheimer's Disease Patients: A Finnish Nationwide Cohort Study.
    J Alzheimers Dis. 2021 Apr 3. pii: JAD201502. doi: 10.3233/JAD-201502.
    PubMed         Abstract available

  17. TSAMOU M, Pistollato F, Roggen EL
    A Tau-Driven Adverse Outcome Pathway Blueprint Toward Memory Loss in Sporadic (Late-Onset) Alzheimer's Disease with Plausible Molecular Initiating Event Plug-Ins for Environmental Neurotoxicants.
    J Alzheimers Dis. 2021 Apr 3. pii: JAD201418. doi: 10.3233/JAD-201418.
    PubMed         Abstract available

  18. BEUCKMANN CT, Suzuki H, Musiek ES, Ueno T, et al
    Evaluation of SAMP8 Mice as a Model for Sleep-Wake and Rhythm Disturbances Associated with Alzheimer's Disease: Impact of Treatment with the Dual Orexin (Hypocretin) Receptor Antagonist Lemborexant.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD201054. doi: 10.3233/JAD-201054.
    PubMed         Abstract available

    Physicians Treating Alzheimer's Disease Patients Should Be Aware that Televised Direct-to-Consumer Advertising Links More Strongly to Drug Utilization in Older Patients.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD210294. doi: 10.3233/JAD-210294.
    PubMed         Abstract available

  20. Erratum Why Inclusion Matters for Alzheimer's Disease Biomarker Discovery in Plasma.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD219318. doi: 10.3233/JAD-219318.

    J Neurol Neurosurg Psychiatry

  21. SINGLETON E, Hansson O, Pijnenburg YAL, La Joie R, et al
    Heterogeneous distribution of tau pathology in the behavioural variant of Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2021 Apr 13. pii: jnnp-2020-325497.
    PubMed         Abstract available

    Neurobiol Aging

  22. BETTCHER BM, Olson KE, Carlson NE, McConnell BV, et al
    Astrogliosis and episodic memory in late life: higher GFAP is related to worse memory and white matter microstructure in healthy aging and Alzheimer's disease.
    Neurobiol Aging. 2021;103:68-77.
    PubMed         Abstract available

    Neurobiol Dis

  23. PETRUSHINA I, Hovakimyan A, Harahap-Carrillo IS, Davtyan H, et al
    Characterization and preclinical evaluation of the cGMP grade DNA based vaccine, AV-1959D to enter the first-in-human clinical trials.
    Neurobiol Dis. 2020;139:104823.
    PubMed         Abstract available

  24. DIOUF I, Bush AI, Ayton S
    Cerebrospinal fluid ceruloplasmin levels predict cognitive decline and brain atrophy in people with underlying beta-amyloid pathology.
    Neurobiol Dis. 2020;139:104810.
    PubMed         Abstract available

  25. HSU S, Pimenova AA, Hayes K, Villa JA, et al
    Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2.
    Neurobiol Dis. 2020;139:104817.
    PubMed         Abstract available

  26. BORRECA A, Valeri F, De Luca M, Ernst L, et al
    Transient upregulation of translational efficiency in prodromal and early symptomatic Tg2576 mice contributes to Abeta pathology.
    Neurobiol Dis. 2020;139:104787.
    PubMed         Abstract available


  27. RENTZ DM, Papp KV, Mayblyum DV, Sanchez JS, et al
    Association of Digital Clock Drawing with PET Amyloid and Tau Pathology in Normal Older Adults.
    Neurology. 2021 Feb 15. pii: WNL.0000000000011697.
    PubMed         Abstract available

  28. HOWARD E, Irwin DJ, Rascovsky K, Nevler N, et al
    Cognitive Profile and Markers of Alzheimer Disease-Type Pathology in Patients With Lewy Body Dementias.
    Neurology. 2021;96:e1855-e1864.
    PubMed         Abstract available

  29. ROBINSON-PAPP J, Saylor D
    HIV in the Brain: From Devastating Dementia to White Matter Hyperintensities.
    Neurology. 2021 Feb 26. pii: WNL.0000000000011735.

    Neurosci Lett

  30. OVSEPIAN SV, O'Leary VB, Hoschl C, Zaborszky L, et al
    Integrated Phylogeny of the Human Brain and Pathobiology of Alzheimer's Disease: A Unifying Hypothesis.
    Neurosci Lett. 2021 Apr 13:135895. doi: 10.1016/j.neulet.2021.135895.
    PubMed         Abstract available

  31. ZHANG Z, Gao W, Wang X, Zhang D, et al
    Geniposide effectively reverses cognitive impairment and inhibits pathological cerebral damage by regulating the mTOR Signal pathway in APPPS1 mice.
    Neurosci Lett. 2020;720:134749.
    PubMed         Abstract available

  32. GKANATSIOU E, Sahlin C, Portelius E, Johannesson M, et al
    Characterization of monomeric and soluble aggregated Abeta in Down's syndrome and Alzheimer's disease brains.
    Neurosci Lett. 2021 Apr 10:135894. doi: 10.1016/j.neulet.2021.135894.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.